Pancreatic Cancer Research

ResearcherIMU UniversityNo recent work listed

Ling‐Wei Hii

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0537-3693; OpenAlex author ID A5033005011. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 3 papers

Papers 6

  1. Novel Gemcitabine-Re(I) Bisquinolinyl Complex Combinations and Formulations With Liquid Crystalline Nanoparticles for Pancreatic Cancer Photodynamic Therapy. Co-author DOI 10.3389/fphar.2022.903210↗
  2. Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer. Co-author DOI 10.3390/cancers14153709↗
  3. Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases. Co-author DOI 10.3748/wjg.v28.i18.1934↗
  4. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion. First author DOI 10.3390/cancers12071872↗
  5. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12906-019-2663-9↗
  6. Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s10495-018-1459-6↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chun‐Wai Mai · 6 shared papers, 2018–2022 · strength 0.86
  2. Chee‐Onn Leong · 5 shared papers, 2018–2022 · strength 0.71
  3. Wynne Sim · 2 shared papers, 2022 · strength 0.37
  4. Li-Lian Gan · 2 shared papers, 2020–2022 · strength 0.31
  5. Chin-King Looi · 1 shared paper, 2022 · strength 0.16
  6. Hui Shan Liew · 1 shared paper, 2022 · strength 0.16
  7. May Lee Low · 1 shared paper, 2022 · strength 0.16
  8. Jia Lin Er · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.